FDA OKs Aurobindo’s generic version of top-selling Parkinson’s drug

Dayton, N.J. — Aurobindo Pharma Limited has announced that it has received final approval from the U.S. Food and Drug Administration for entacapone tablets USP, 200 mg, the generic equivalent to Comtan Tablets 200 mg.

Comtan, which is used in the treatment of Parkinson’s disease, was one of Novartis’ top 20 top-selling drugs in 2014, with sales totaling $371 million.